News Website

Endometriosis: ‘I was feeling like a burden, feeling like it was all in my head’ - BBC

Endometriosis: ‘I was feeling like a burden, feeling like it was all in my head’ BBC

Published: April 24, 2024, 7 a.m.

Read Full Article

GSK's endometrial cancer drug receives FDA approval - ShareCast

GSK's endometrial cancer drug receives FDA approval ShareCast

Published: April 24, 2024, 7 a.m.

Read Full Article

Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting - PR Newswire

Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting PR Newswire

Published: April 24, 2024, 7 a.m.

Read Full Article

Education Session to Discuss the Implementation of New Drugs in Gynecologic Oncology - ASCO Daily News

Education Session to Discuss the Implementation of New Drugs in Gynecologic Oncology ASCO Daily News

Published: April 24, 2024, 7 a.m.

Read Full Article

Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting - Investor Relations | Karyopharm Therapeutics

Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting Investor Relations | Karyopharm Therapeutics

Published: April 24, 2024, 7 a.m.

Read Full Article

Endometriosis in infertile women: an observational and comparative study of quality of life, anxiety, and depression - BioMed Central

Endometriosis in infertile women: an observational and comparative study of quality of life, anxiety, and depression BioMed Central

Published: April 23, 2024, 7 a.m.

Read Full Article

Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses - Nature.com

Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses Nature.com

Published: April 23, 2024, 7 a.m.

Read Full Article

The backlash against Rigevidon: why are women speaking out against this pill? - Cosmopolitan UK

The backlash against Rigevidon: why are women speaking out against this pill? Cosmopolitan UK

Published: April 23, 2024, 7 a.m.

Read Full Article

Princess Kate, Sam Kerr, and NRL in Vegas: News reaches 20.7m people in March - Mediaweek

Princess Kate, Sam Kerr, and NRL in Vegas: News reaches 20.7m people in March Mediaweek

Published: April 23, 2024, 7 a.m.

Read Full Article

$400,000 awarded to ovarian cancer researchers - fredhutch.org

$400,000 awarded to ovarian cancer researchers fredhutch.org

Published: April 22, 2024, 7 a.m.

Read Full Article

Latest Articles

Endometriosis: ‘I was feeling like a burden, feeling like it was all in my head’ - BBC

GSK's endometrial cancer drug receives FDA approval - ShareCast

Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting - PR Newswire

Education Session to Discuss the Implementation of New Drugs in Gynecologic Oncology - ASCO Daily News

Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting - Investor Relations | Karyopharm Therapeutics

Endometriosis in infertile women: an observational and comparative study of quality of life, anxiety, and depression - BioMed Central

Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses - Nature.com

The backlash against Rigevidon: why are women speaking out against this pill? - Cosmopolitan UK

Princess Kate, Sam Kerr, and NRL in Vegas: News reaches 20.7m people in March - Mediaweek

$400,000 awarded to ovarian cancer researchers - fredhutch.org

Subscribe to Our Newsletter